Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of inhaled budesonide treatment duration in cough variant asthma
ChiCTR-TRC-13003395Phase 4Completed
- Sponsor
- Huashan Hospital
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide in cough variant asthma (CVA) (3 arms), sponsored by Huashan Hospital. Primary endpoints: IL-5 in induced sputum, IL-10 in induced sputum and 3 more. Started Jul 2013; status: completed.
02
Drugs
budesonide
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR-TRC-13003395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003395.